USC Norris
>
Clinical Trials
Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
IRB
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
» Contact Us
» Glossary
If you are a patient, please contact
Keck Medical Center of USC
at 800-USC-CARE.
Trial 9L-18-9
A Phase 2 Study of Ibrutinib and Blinatumomab in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
Type:
Treatment
Phase:
Phase II
Status:
Open to Accrual
Treatments:
Chemotherapy: Systemic
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
George Yaghmour, M.D.
Other Trial Staff:
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.